Welcome to the new scientist and researcher reference section. Your one-stop shop for the essential resources you need to advance your career.
Choose from more than 200 Educational Sessions!
The SNMMI 2019 Annual Meeting—featuring eight categorical seminars, more than 120 CE and 80 scientifi c sessions, as well as several specialty workshops and an extensive scientific poster hall—will provide you with an in-depth view of the latest research, development, and clinical applications helping to advance targeted, personalized medicine.
Celebrating Past and Future Innovations in Instrumentation
In the 60 years since the introduction of the Anger Camera, the development of new state-ofthe-art instrumentation has been at the heart of nuclear medicine progress. The plenary sessions will showcase speakers who are true innovators in nuclear medicine instrumentation.
Highlight Country: Canada
SNMMI is pleased to welcome Canada as this year’s Highlight Country. The Canadian Nuclear Medicine Association present at the Opening Ceremony, organize four continuing education sessions, and introduce attendees to aspects of Canadian culture.
Taking in the Southern California Lifestyle
Anaheim - with its convenient Southern California location, beautiful weather, and wide variety of activities - is the perfect host city for our meeting. Home to Disneyland, the Los Angeles Angels and their legendary stadium, the Big A, the fourth oldest baseball stadium in major league baseball, Anaheim’s central location serves as a convenient gateway to Orange County’s 42 miles of Pacific Ocean coastline, luxury shopping, championship golf courses, and terrain for hiking, biking, running, and sunning.
The most up-to-date and comprehensive source for nuclear medicine coding and reimbursement information on the web. Please note that ALL information and materials within the SNMMI Coding Corner are direct products of the SNMMI Coding and Reimbursement Working Group.
For Hospitals (APCs, IPPS) Find general coding and reimbursement information for hospitals.
For Private Practices (RBRVS) Find general coding and reimbursement information for professionals in private practices.
Coding and Reimbursement Q&A This easy to use feature contains over 100 questions and answers related to topics such as cardiac, endocrine, neurology, nuclear medicine-related drugs, oncology, PET, PET/CT, radiopharmaceuticals, and more!
In nuclear medicine and molecular imaging, small amounts of radioactive agents are administered to the patient to allow the physician to examine molecular processes within the body. These procedures are highly effective, safe and painless diagnostic tools that present physicians with a detailed view of what’s going on inside an individual’s body at the cellular level. For more than 60 years, these studies have been used to evaluate practically all systems within the body, including the heart and brain, as well as to image many types of cancer.
SNMMI has a large body of knowledge in dose optimization that is continually growing and developing. The dose optimization website presents a wide variety of resources, including SNMMI journal articles, educational offerings, media-related information, links to useful websites and more.
The practice guidelines help to identify those elements of the procedure that are most important in obtaining a high-quality examination, while simultaneously controlling costs. Use of standardized procedures will increase the applicability of clinical research among multiple institutions, in turn, increasing the value of research studies, particularly in the field of technology assessment. In the interest of creating strong, comprehensive documents, some guidelines were formally adopted by SNMMI in collaboration with other professional organizations.
SNMMI's Center for Molecular Imaging Innovation and Translation is an organizational component within the SNMMI that is dedicated to all aspects of molecular imaging in the detection and management of disease. The center is currently facilitating initiatives to bring molecular imaging discoveries from the lab to the patient and to advance "personalized" medicine.
The Clinical Trials Network’s mission is to advance the use of molecular imaging radiopharmaceuticals in clinical trials through standardization of chemistry and imaging methodology. This includes using imaging radiopharmaceuticals during the course of drug development, as well as bringing new agents to regulatory approval. Click here to learn more about the CTN’s Oncology and Neurology Scanner Validation programs, ongoing efforts to harmonize reconstruction parameters in oncology clinical trials, and other services that CTN offers to help scientists advance their research.
SNMMI educational programs are designed to meet the professional development needs of scientists involved in nuclear medicine and molecular imaging endeavors.
A novel therapy using two targeted treatments for prostate cancer has been shown to maximize efficacy while reducing side effects.
Two research studies offer hope for effective treatment and prevention on acute kidney injury.
Research presented at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNM MI) shows preliminary evidence that tobacco smokers may have reduced neuroimmune function compared with nonsmokers.
Peptide receptor radionuclide therapy (PRRT) has been shown to be safe and effective for patients with grade 3 (G3) neuroendocrine neoplasms (NENs), according to research presented at SNMMI's 2019 Annual Meeting.
SNMMI monitors multiple federal legislative issues and provides resources including issue summaries, letters to Congress, and analysis. Most of this information is in the government relations news section of this web site.
Tools, supported by evidence, to harmonize the practice of nuclear medicine using a progressive and safe approach.